Effector Therapeutics Stock Price History

EFTR Stock  USD 1.85  0.09  4.64%   
If you're considering investing in Effector Stock, it is important to understand the factors that can impact its price. As of today, the current price of Effector Therapeutics stands at 1.85, as last reported on the 24th of April, with the highest price reaching 2.00 and the lowest price hitting 1.78 during the day. Effector Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0627, which denotes the company had a -0.0627% return per unit of risk over the last 3 months. Effector Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Effector Therapeutics' Variance of 150.82, standard deviation of 12.28, and Mean Deviation of 6.86 to check the risk estimate we provide.
  
At this time, Effector Therapeutics' Liabilities And Stockholders Equity is relatively stable compared to the past year. As of 04/24/2024, Sale Purchase Of Stock is likely to grow to about 67.6 K, while Common Stock Shares Outstanding is likely to drop slightly above 1.5 M. . As of 04/24/2024, Price To Sales Ratio is likely to drop to 4.24. In addition to that, Price Earnings Ratio is likely to grow to -0.68. Effector Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0627

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsEFTR

Estimated Market Risk

 12.52
  actual daily
96
96% of assets are less volatile

Expected Return

 -0.79
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.06
  actual daily
0
Most of other assets perform better
Based on monthly moving average Effector Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Effector Therapeutics by adding Effector Therapeutics to a well-diversified portfolio.
Price Book
13.3845
Enterprise Value Ebitda
(0.30)
Price Sales
69.6486
Shares Float
3.4 M
Wall Street Target Price
11

Effector Therapeutics Stock Price History Chart

There are several ways to analyze Effector Stock price data. The simplest method is using a basic Effector candlestick price chart, which shows Effector Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMarch 4, 202416.95
Lowest PriceApril 19, 20241.7

Effector Therapeutics April 24, 2024 Stock Price Synopsis

Various analyses of Effector Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Effector Stock. It can be used to describe the percentage change in the price of Effector Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Effector Stock.
Effector Therapeutics Price Daily Balance Of Power(0.41)
Effector Therapeutics Price Rate Of Daily Change 0.95 
Effector Therapeutics Price Action Indicator(0.08)

Effector Therapeutics April 24, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Effector Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Effector Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Effector Stock and then apply it to test your longer-term investment strategies against Effector.

Effector Stock Price History Data

The price series of Effector Therapeutics for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 has a statistical range of 15.25 with a coefficient of variation of 44.95. Under current investment horizon, the daily prices are spread out with arithmetic mean of 10.08. The median price for the last 90 days is 11.06. The company completed 1:25 stock split on 12th of January 2024.
OpenHighLowCloseVolume
04/24/2024
 1.94  2.00  1.78  1.85 
04/23/2024 1.80  2.00  1.78  1.94  149,613 
04/22/2024 1.67  1.87  1.63  1.78  177,227 
04/19/2024 1.80  1.80  1.60  1.70  197,073 
04/18/2024 1.91  1.91  1.75  1.78  146,195 
04/17/2024 2.01  2.05  1.81  1.89  136,014 
04/16/2024 1.89  2.03  1.89  1.99  234,386 
04/15/2024 2.12  2.12  1.83  1.93  412,408 
04/12/2024 2.27  2.27  2.03  2.08  294,306 
04/11/2024 2.34  2.37  2.17  2.24  347,235 
04/10/2024 2.31  2.39  2.24  2.36  255,813 
04/09/2024 2.17  2.46  2.14  2.31  818,706 
04/08/2024 2.44  2.44  2.10  2.13  1,336,570 
04/05/2024 2.89  2.95  2.49  2.51  2,398,972 
04/04/2024 3.60  4.10  2.76  2.96  8,725,275 
04/03/2024 15.26  16.88  15.07  16.47  246,976 
04/02/2024 15.50  16.12  14.03  15.41  126,640 
04/01/2024 14.37  16.55  13.96  15.67  350,293 
03/28/2024 13.25  14.72  13.25  14.39  351,712 
03/27/2024 12.82  13.72  12.38  13.45  164,382 
03/26/2024 12.29  13.49  11.10  12.91  487,638 
03/25/2024 12.97  14.28  12.55  13.76  325,055 
03/22/2024 12.58  12.91  12.00  12.33  86,368 
03/21/2024 12.88  13.15  11.69  12.95  143,724 
03/20/2024 12.50  12.85  12.05  12.85  58,640 
03/19/2024 11.96  12.95  11.71  12.27  79,745 
03/18/2024 11.30  13.15  11.30  11.87  156,695 
03/15/2024 10.88  11.34  10.81  11.06  114,477 
03/14/2024 10.76  11.27  10.75  10.85  75,530 
03/13/2024 11.11  11.55  10.50  10.88  127,529 
03/12/2024 10.85  11.83  10.51  11.15  158,752 
03/11/2024 13.25  13.62  10.85  11.12  414,055 
03/08/2024 14.62  15.25  12.36  13.16  465,816 
03/07/2024 16.56  16.74  14.93  14.99  159,679 
03/06/2024 16.00  16.92  15.38  16.68  172,756 
03/05/2024 17.19  17.22  15.11  15.57  264,664 
03/04/2024 16.99  17.75  16.01  16.95  310,275 
03/01/2024 14.40  16.67  14.05  16.20  291,876 
02/29/2024 13.59  14.44  12.81  14.44  162,658 
02/28/2024 13.50  15.00  13.44  13.59  343,880 
02/27/2024 11.62  13.54  11.62  13.14  360,402 
02/26/2024 11.07  11.92  11.03  11.62  100,284 
02/23/2024 11.17  11.27  10.74  11.12  78,212 
02/22/2024 10.90  11.29  10.50  11.04  77,781 
02/21/2024 11.11  11.34  10.42  10.84  68,064 
02/20/2024 11.50  11.93  10.60  10.99  102,103 
02/16/2024 11.59  11.90  11.25  11.32  61,298 
02/15/2024 12.12  12.64  11.29  11.66  136,925 
02/14/2024 11.00  12.27  10.45  12.19  204,085 
02/13/2024 10.80  11.43  10.62  10.99  60,731 
02/12/2024 10.60  11.09  10.40  10.77  86,758 
02/09/2024 10.44  11.00  10.27  10.70  44,164 
02/08/2024 10.09  10.65  9.78  10.51  45,940 
02/07/2024 10.37  10.37  9.78  9.95  36,908 
02/06/2024 10.16  10.40  10.08  10.34  57,287 
02/05/2024 10.57  10.82  9.80  10.11  50,297 
02/02/2024 11.03  11.18  10.28  10.56  111,220 
02/01/2024 11.49  11.87  10.95  11.19  107,466 
01/31/2024 10.79  11.60  10.79  11.47  55,602 
01/30/2024 11.44  11.95  10.49  11.32  118,944 
01/29/2024 10.43  12.00  10.43  11.70  187,635 

About Effector Therapeutics Stock history

Effector Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Effector is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Effector Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Effector Therapeutics stock prices may prove useful in developing a viable investing in Effector Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding2.2 M1.5 M
Net Loss-20.4 M-19.4 M

Effector Therapeutics Stock Technical Analysis

Effector Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Effector Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Effector Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Funds Screener Now

   

Funds Screener

Find actively-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module

Effector Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Effector Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Effector Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Effector to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Effector Therapeutics is a strong investment it is important to analyze Effector Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Effector Therapeutics' future performance. For an informed investment choice regarding Effector Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Effector Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Effector Stock, please use our How to Invest in Effector Therapeutics guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Effector Stock analysis

When running Effector Therapeutics' price analysis, check to measure Effector Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Effector Therapeutics is operating at the current time. Most of Effector Therapeutics' value examination focuses on studying past and present price action to predict the probability of Effector Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Effector Therapeutics' price. Additionally, you may evaluate how the addition of Effector Therapeutics to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stocks Directory
Find actively traded stocks across global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Is Effector Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Effector Therapeutics. If investors know Effector will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Effector Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(16.37)
Revenue Per Share
0.349
Quarterly Revenue Growth
1.17
Return On Assets
(0.85)
Return On Equity
(9.47)
The market value of Effector Therapeutics is measured differently than its book value, which is the value of Effector that is recorded on the company's balance sheet. Investors also form their own opinion of Effector Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Effector Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Effector Therapeutics' market value can be influenced by many factors that don't directly affect Effector Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Effector Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Effector Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Effector Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.